Atropine sulfate and Midazolam hydrochloride drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Atropine sulfate and Midazolam hydrochloride together. This study is created by eHealthMe based on reports of 17 people who take Atropine sulfate and Midazolam hydrochloride from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on atropine sulfate and midazolam hydrochloride (the active ingredients of Atropine sulfate and Midazolam hydrochloride, respectively), and Atropine sulfate and Midazolam hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Atropine sulfate?

Atropine sulfate has active ingredients of atropine sulfate. (latest outcomes from Atropine sulfate 2,064 users)

What is Midazolam hydrochloride?

Midazolam hydrochloride has active ingredients of midazolam hydrochloride. It is often used in insomnia. (latest outcomes from Midazolam hydrochloride 1,216 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

17 people who take Atropine sulfate, Midazolam hydrochloride are studied.


Number of reports submitted per year:

Atropine sulfate and Midazolam hydrochloride drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Haematuria (presence of blood in urine)
  2. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  3. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  4. Post procedural complication
  5. Proteinuria (presence of protein in the urine)
  6. Renal failure acute (rapid kidney dysfunction)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  9. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  10. Fungal infection
1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Hypokalaemia (low potassium)
  5. Pain
  6. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  7. Blood pressure decreased
  8. Cardiac disorder
  9. Cardiac failure
  10. Cerebral infarction (less blood supply to brain resulting tissue damage)

Most common drug interactions by gender *:

female:
  1. Blood pressure decreased
  2. Cerebral infarction (less blood supply to brain resulting tissue damage)
  3. Disturbance in attention
  4. Gastroenteritis (inflammation of stomach and intestine)
  5. Haematuria (presence of blood in urine)
  6. Heart rate decreased
  7. Iatrogenic injury (iatrogenic injury is a form of medical error)
  8. Oliguria (not enough urine)
  9. Procedural complication
  10. Renal failure acute (rapid kidney dysfunction)
male:
  1. Respiratory failure (inadequate gas exchange by the respiratory system)
  2. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  3. Cardiac failure
  4. Constipation
  5. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  6. Drug effect decreased
  7. Drug ineffective
  8. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  9. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  10. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)

Most common drug interactions by age *:

0-1:
  1. Hypokalaemia (low potassium)
  2. Long qt syndrome (disorder of the heart's electrical system)
  3. Ventricular fibrillation (abnormally irregular heart rhythm)
2-9:

n/a

10-19:
  1. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Anaesthetic complication
  4. Constipation
  5. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  6. Infection
  7. Lymphocyte stimulation test positive
  8. Post procedural complication
20-29:
  1. Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
  2. Cardiac disorder
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Hypotension (abnormally low blood pressure)
30-39:
  1. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  2. Phlebitis (inflammation of the walls of a vein)
  3. Renal impairment (severely reduced kidney function)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
40-49:
  1. Haematuria (presence of blood in urine)
  2. Oliguria (not enough urine)
  3. Renal failure acute (rapid kidney dysfunction)
50-59:

n/a

60+:
  1. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  2. Pain
  3. Drug ineffective
  4. Epidermal necrolysis (skin condition that is usually caused by a reaction to drugs)
  5. Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
  6. Flatulence (flatus expelled through the anus)
  7. Fungal infection
  8. Gastroenteritis (inflammation of stomach and intestine)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Heart rate decreased

* Approximation only. Some reports may have incomplete information.


Do you take Atropine sulfate and Midazolam hydrochloride?

You are not alone:




Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Atropine sulfate and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Midazolam hydrochloride and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Atropine sulfate and Midazolam hydrochloride
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Atropine sulfate and Midazolam hydrochloride



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.